Dr. Hope on the Future of Imaging for Biochemical Recurrent Prostate Cancer

Thomas Hope, MD, assistant professor of abdominal imaging and nuclear medicine at University of California, San Francisco (UCSF), discusses the future of imaging for biochemical recurrent prostate cancer.

Hope says that it is important to understand how novel imaging techniques such as PSMA-PET effect care by including them in clinical trials, as well as demonstrating when they should be used.